A recent development in treating pancreatic cancer offers new hope. After extensive research, an innovative experimental drug has emerged, taken once a day. This drug is showing effectiveness in prolonging the lives of patients.
By focusing on slowing the progression of pancreatic cancer, which is known for its low survival rates, this drug could change the outlook for many individuals diagnosed with the disease.
Dr. Rachna Shroff, who serves as the associate director of clinical investigations at the University of Arizona Comprehensive Cancer Center, contributes insights to the ongoing efforts in combating this cancer.
In an interview with Stephanie Sy, PBS News Hour correspondent, Dr. Shroff discusses the implications of this breakthrough. Stephanie Sy, a seasoned journalist, has extensive experience with PBS News Hour, Al Jazeera America, CNN International, and other major news outlets. Her reporting has covered significant events, including the 2018 Midterm Elections and providing live reports from key political moments.
Increased Funding Needed for Psychiatric Hospitals 
Trump Administration Distributes ACA Refund Checks 
Higher Consumption of Ultra-Processed Foods Linked to Increased Health Risks 
Understanding Inflammation: Myths and Facts 
Calm Parenting: Strategies to Manage Stress 
Trump’s Executive Order to Combat Mosquitoes and Ticks in D.C.